WCN26-9281 Experience with Avacopan for the Treatment of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV) in the Nephrology Department of Nishi-Kobe Medical Center
Kidney International Reports · 2026-04 · 11 (4) · 106331
DOI: 10.1016/j.ekir.2026.106331 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney International Reports, 2026-04. Verfasst von Hiroko Kakita und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kakita, H., Suetake, T., Otsuka, K., Nakata, Y., & Hagihara, K. (2026). WCN26-9281 Experience with Avacopan for the Treatment of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV) in the Nephrology Department of Nishi-Kobe Medical Center. Kidney International Reports, 11(4), 106331. https://doi.org/10.1016/j.ekir.2026.106331
Vancouver
Kakita H, Suetake T, Otsuka K, Nakata Y, Hagihara K. WCN26-9281 Experience with Avacopan for the Treatment of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV) in the Nephrology Department of Nishi-Kobe Medical Center. Kidney International Reports. 2026;11(4):106331. doi:10.1016/j.ekir.2026.106331
BibTeX
@article{Kakita2026,
author = {Kakita, Hiroko and Suetake, Tomoki and Otsuka, Kansei and Nakata, Yosuke and Hagihara, Koichiro},
title = {WCN26-9281 Experience with Avacopan for the Treatment of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV) in the Nephrology Department of Nishi-Kobe Medical Center},
journal = {Kidney International Reports},
year = {2026},
volume = {11},
number = {4},
pages = {106331},
doi = {10.1016/j.ekir.2026.106331}
}
EUVIMED